See more : Minerals Technologies Inc. (MTX) Income Statement Analysis – Financial Results
Complete financial analysis of Shanghai Haoyuan Chemexpress Co., Ltd. (688131.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Shanghai Haoyuan Chemexpress Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Compass Group PLC (CMPGF) Income Statement Analysis – Financial Results
- Soluciones Cuatroochenta S.L. (480S.MC) Income Statement Analysis – Financial Results
- Nanofilm Technologies International Limited (MZH.SI) Income Statement Analysis – Financial Results
- Swicorp Wabel Reit Fund (4345.SR) Income Statement Analysis – Financial Results
- Kanishk Steel Industries Limited (KANSHST.BO) Income Statement Analysis – Financial Results
Shanghai Haoyuan Chemexpress Co., Ltd. (688131.SS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.chemexpress.cn
About Shanghai Haoyuan Chemexpress Co., Ltd.
Shanghai Haoyuan Chemexpress Co., Ltd. researches and develops pharmaceutical intermediates and small molecule drugs. It manufactures APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.88B | 1.36B | 969.23M | 635.10M | 408.97M | 300.20M | 173.97M | 117.08M | 91.93M | 67.09M | 58.62M |
| Cost of Revenue | 1.11B | 659.41M | 444.70M | 275.16M | 175.12M | 145.40M | 83.31M | 61.28M | 63.53M | 49.12M | 44.84M |
| Gross Profit | 766.71M | 698.64M | 524.52M | 359.94M | 233.85M | 154.80M | 90.65M | 55.80M | 28.41M | 17.96M | 13.78M |
| Gross Profit Ratio | 40.78% | 51.44% | 54.12% | 56.67% | 57.18% | 51.57% | 52.11% | 47.66% | 30.90% | 26.78% | 23.51% |
| Research & Development | 224.12M | 201.58M | 103.45M | 64.80M | 53.04M | 35.42M | 28.19M | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 56.91M | 52.43M | 38.30M | 25.99M | 13.17M | 32.34M | 13.57M | 27.87M | 15.79M | 11.95M | 9.62M |
| Selling & Marketing | 61.55M | 110.15M | 69.60M | 49.02M | 47.14M | 32.25M | 18.56M | 9.06M | 4.25M | 2.70M | 2.05M |
| SG&A | 389.04M | 162.58M | 107.90M | 75.01M | 60.31M | 64.59M | 32.13M | 36.92M | 20.04M | 14.66M | 11.68M |
| Other Expenses | 25.23M | 98.71M | 63.46M | 30.31M | 23.54M | 39.74K | -1.64K | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 638.39M | 462.88M | 274.81M | 170.12M | 136.89M | 116.58M | 63.73M | 35.59M | 19.24M | 14.96M | 11.59M |
| Cost & Expenses | 1.75B | 1.12B | 719.51M | 445.28M | 312.01M | 261.98M | 147.04M | 96.87M | 82.76M | 64.09M | 56.42M |
| Interest Income | 3.21M | 9.71M | 12.65M | 2.38M | 2.03M | 65.05K | 118.42K | 0.00 | 0.00 | 0.00 | 375.53K |
| Interest Expense | 38.61M | 16.86M | 9.50M | 2.63M | 1.64M | 1.86M | 766.61K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 123.22M | 88.76M | 51.20M | 11.18M | 7.54M | 5.04M | 2.33M | 1.71M | 1.34M | 713.37K | 458.14K |
| EBITDA | 275.12M | 309.65M | 274.53M | 162.77M | 93.84M | 31.48M | 19.26M | 20.50M | 9.57M | 3.93M | 2.50M |
| EBITDA Ratio | 14.63% | 24.85% | 30.00% | 30.35% | 25.43% | 13.98% | 16.99% | 17.51% | 10.41% | 5.86% | 4.26% |
| Operating Income | 128.33M | 271.24M | 209.75M | 148.69M | 84.38M | 23.96M | 16.17M | 18.79M | 8.23M | 3.22M | 2.04M |
| Operating Income Ratio | 6.83% | 19.97% | 21.64% | 23.41% | 20.63% | 7.98% | 9.30% | 16.05% | 8.96% | 4.79% | 3.48% |
| Total Other Income/Expenses | -136.04K | 1.98M | -233.42K | -75.36K | -25.62K | 39.74K | -1.64K | 3.02M | 1.53M | -217.39K | 628.15K |
| Income Before Tax | 128.19M | 198.54M | 209.52M | 148.61M | 84.36M | 24.00M | 16.17M | 20.22M | 9.17M | 3.00M | 2.57M |
| Income Before Tax Ratio | 6.82% | 14.62% | 21.62% | 23.40% | 20.63% | 8.00% | 9.29% | 17.27% | 9.97% | 4.47% | 4.39% |
| Income Tax Expense | 1.88M | 6.99M | 18.95M | 20.18M | 10.93M | 5.59M | 1.16M | 2.19M | 634.15K | 152.13K | 250.35K |
| Net Income | 127.45M | 193.64M | 190.98M | 128.43M | 73.43M | 18.41M | 15.01M | 18.02M | 8.54M | 3.15M | 2.32M |
| Net Income Ratio | 6.78% | 14.26% | 19.70% | 20.22% | 17.95% | 6.13% | 8.63% | 15.39% | 9.28% | 4.70% | 3.96% |
| EPS | 0.61 | 0.93 | 0.94 | 0.63 | 0.36 | 0.09 | 0.08 | 0.11 | 0.05 | 2.10 | 0.44 |
| EPS Diluted | 0.61 | 0.93 | 0.94 | 0.63 | 0.36 | 0.09 | 0.08 | 0.11 | 0.05 | 2.10 | 0.44 |
| Weighted Avg Shares Out | 209.92M | 208.78M | 203.99M | 203.99M | 203.99M | 203.99M | 187.18M | 169.60M | 158.81M | 120.05M | 105.82M |
| Weighted Avg Shares Out (Dil) | 209.92M | 208.78M | 203.99M | 203.99M | 203.99M | 203.99M | 187.18M | 169.60M | 158.81M | 120.05M | 105.82M |
Source: https://incomestatements.info
Category: Stock Reports